Showing 1431-1440 of 1775 results for "".
CXL: What It Is, and When to Refer
https://modernod.com/mod-issues/2020-mar/cxl-what-it-is-and-when-to-refer/39098/A US clinical trial of epi-on corneal collagen crosslinking is expected to be completed this year.Comanaging Glaucoma Patients Through Cataract Surgery
https://modernod.com/mod-issues/2019-apr/comanaging-glaucoma-patients-through-cataract-surgery/39058/Optometrists have a growing opportunity to collaborate in the care of these patients.A Review of Pharmacologic Treatments for Presbyopia
https://modernod.com/topics/presbyopia/a-review-of-pharmacologic-treatments-for-presbyopia/39027/With several therapies on the market, understanding their differences is the key to optimizing clinical decision making.Comfort of Dailies Total1® for Astigmatism in Symptomatic Habitual Reusable Toric Lens Wearers
https://modernod.com/mod-issues/supplements-inserts/comfort-of-dailies-total1-for-astigmatism-in-symptomatic-habitual-reusable-toric-lens-wearers/38882/The Future of Eye Care for Children
https://modernod.com/topics/health-policy/the-future-of-eye-care-for-children/38825/Part one of this multi-part series analyzes proposed legislation to support early eye care intervention in children.Expanding the Corneal Topical Therapy Arsenal
https://modernod.com/topics/corneaanterior-segment/expanding-the-corneal-topical-therapy-arsenal/38807/Three emerging medications to add to your toolkit, each for a different corneal indication.Ophthalmic Presentations of Pituitary Adenoma
https://modernod.com/mod-issues/2020-nov-dec/ophthalmic-presentations-of-pituitary-adenoma/39115/The ocular examination can aid diagnosis and help guide treatment.Myopia: a Global Epidemic
https://modernod.com/mod-issues/2019-nov-dec/myopia-a-global-epidemic/39091/An overview of the problem and efforts to address it.- OD-OS Achieves Revocation of Iridex MicroPulse Patenthttps://modernod.com/news/od-os-achieves-revocation-of-iridex-micropulse-patent/2480020/OD-OS has achieved the revocation of the MicroPulse Patent (Patent no EP1856774) by Iridex Corporation in oral proceedings at the European Patent office held last Friday in Munich, Germany according to an OD-OS news release. With its successful opposition, OD-OS has cleared the path to man
- OD-OD Introduces a New Learning App for Retinal Laser Treatmenthttps://modernod.com/news/od-od-introduces-a-new-learning-app-for-retinal-laser-treatment/2479529/To address growing demand for interactive learning technology, OD-OS has developed a tool for implementing a better approach to retinal laser treatment: The Navigate App. Navigate is a free, interactive tool designed to support residents and team education—both onsite and online. The platf